Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances.

Varshneya NB, Walentiny DM, Moisa LT, Walker TD, Akinfiresoye LR, Beardsley PM.

Neuropharmacology. 2019 Mar 20. pii: S0028-3908(18)30829-3. doi: 10.1016/j.neuropharm.2019.03.023. [Epub ahead of print]

PMID:
30904478
2.

Oxycodone-like discriminative stimulus effects of fentanyl-related emerging drugs of abuse in mice.

Walentiny DM, Moisa LT, Beardsley PM.

Neuropharmacology. 2019 Feb 5. pii: S0028-3908(18)30828-1. doi: 10.1016/j.neuropharm.2019.02.007. [Epub ahead of print]

PMID:
30735691
3.

Synthetic Opioids.

Beardsley PM, Zhang Y.

Handb Exp Pharmacol. 2018;252:353-381. doi: 10.1007/164_2018_149.

PMID:
30242482
4.

Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice.

Walentiny DM, Wiebelhaus JM, Beardsley PM.

Drug Alcohol Depend. 2018 Jun 1;187:335-342. doi: 10.1016/j.drugalcdep.2018.02.035. Epub 2018 Apr 15.

PMID:
29705547
5.

Glial and neuroinflammatory targets for treating substance use disorders.

Bachtell RK, Jones JD, Heinzerling KG, Beardsley PM, Comer SD.

Drug Alcohol Depend. 2017 Nov 1;180:156-170. doi: 10.1016/j.drugalcdep.2017.08.003. Epub 2017 Aug 31. Review.

6.

Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.

Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH.

Neuropharmacology. 2017 Oct;125:80-86. doi: 10.1016/j.neuropharm.2017.06.032. Epub 2017 Jun 30.

7.

Initial characterization of behavior and ketamine response in a mouse knockout of the post-synaptic effector gene Anks1b.

Enga RM, Rice AC, Weller P, Subler MA, Lee D, Hall CP, Windle JJ, Beardsley PM, van den Oord EJ, McClay JL.

Neurosci Lett. 2017 Feb 22;641:26-32. doi: 10.1016/j.neulet.2017.01.044. Epub 2017 Jan 20.

8.

Design principles for effective video-based professional development.

Roth KJ, Bintz J, Wickler NIZ, Hvidsten C, Taylor J, Beardsley PM, Caine A, Wilson CD.

Int J STEM Educ. 2017;4(1):31. doi: 10.1186/s40594-017-0091-2. Epub 2017 Nov 24.

9.

Oxycodone physical dependence and its oral self-administration in C57BL/6J mice.

Enga RM, Jackson A, Damaj MI, Beardsley PM.

Eur J Pharmacol. 2016 Oct 15;789:75-80. doi: 10.1016/j.ejphar.2016.07.006. Epub 2016 Jul 5.

10.

Ibudilast attenuates expression of behavioral sensitization to cocaine in male and female rats.

Poland RS, Hahn Y, Knapp PE, Beardsley PM, Bowers MS.

Neuropharmacology. 2016 Oct;109:281-292. doi: 10.1016/j.neuropharm.2016.06.024. Epub 2016 Jun 22.

11.

Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice.

Owens RA, Ignatowska-Jankowska B, Mustafa M, Beardsley PM, Wiley JL, Jali A, Selley DE, Niphakis MJ, Cravatt BF, Lichtman AH.

J Pharmacol Exp Ther. 2016 Aug;358(2):306-14. doi: 10.1124/jpet.115.229492. Epub 2016 Jun 15.

12.

Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.

Fitting S, Stevens DL, Khan FA, Scoggins KL, Enga RM, Beardsley PM, Knapp PE, Dewey WL, Hauser KF.

J Pharmacol Exp Ther. 2016 Jan;356(1):96-105. doi: 10.1124/jpet.115.226407. Epub 2015 Nov 5.

13.

Effects of Acute and Repeated Administration of Oxycodone and Naloxone-Precipitated Withdrawal on Intracranial Self-Stimulation in Rats.

Wiebelhaus JM, Walentiny DM, Beardsley PM.

J Pharmacol Exp Ther. 2016 Jan;356(1):43-52. doi: 10.1124/jpet.115.228940. Epub 2015 Oct 21.

14.

The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile.

Vengeliene V, Moeller A, Meinhardt MW, Beardsley PM, Sommer WH, Spanagel R, Bespalov A.

Neuropsychopharmacology. 2016 Mar;41(4):979-88. doi: 10.1038/npp.2015.225. Epub 2015 Jul 28.

15.

Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration.

McClay JL, Vunck SA, Batman AM, Crowley JJ, Vann RE, Beardsley PM, van den Oord EJ.

J Neuroimmune Pharmacol. 2015 Sep;10(3):425-34. doi: 10.1007/s11481-015-9605-1. Epub 2015 Apr 8.

16.

The genetic architecture of traits associated with the evolution of self-pollination in Mimulus.

Fishman L, Beardsley PM, Stathos A, Williams CF, Hill JP.

New Phytol. 2015 Jan;205(2):907-17. doi: 10.1111/nph.13091. Epub 2014 Oct 13.

17.

Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.

Wiley JL, Walentiny DM, Wright MJ Jr, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE.

Eur J Pharmacol. 2014 Aug 15;737:97-105. doi: 10.1016/j.ejphar.2014.05.013. Epub 2014 May 22.

18.

Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphine.

El-Hage N, Rodriguez M, Podhaizer EM, Zou S, Dever SM, Snider SE, Knapp PE, Beardsley PM, Hauser KF.

AIDS. 2014 Jun 19;28(10):1409-19. doi: 10.1097/QAD.0000000000000291.

19.

Glial modulators as potential treatments of psychostimulant abuse.

Beardsley PM, Hauser KF.

Adv Pharmacol. 2014;69:1-69. doi: 10.1016/B978-0-12-420118-7.00001-9. Review.

20.

Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization.

Adkins DE, McClay JL, Vunck SA, Batman AM, Vann RE, Clark SL, Souza RP, Crowley JJ, Sullivan PF, van den Oord EJ, Beardsley PM.

Genes Brain Behav. 2013 Nov;12(8):780-91. doi: 10.1111/gbb.12081. Epub 2013 Sep 30.

21.

Chromosomal rearrangements and the genetics of reproductive barriers in mimulus (monkey flowers).

Fishman L, Stathos A, Beardsley PM, Williams CF, Hill JP.

Evolution. 2013 Sep;67(9):2547-60. doi: 10.1111/evo.12154. Epub 2013 May 28.

PMID:
24033166
22.

Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions.

Aberg KA, Xie LY, McClay JL, Nerella S, Vunck S, Snider S, Beardsley PM, van den Oord EJ.

Epigenomics. 2013 Aug;5(4):367-77. doi: 10.2217/epi.13.36.

23.

Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure.

McClay JL, Adkins DE, Vunck SA, Batman AM, Vann RE, Clark SL, Beardsley PM, van den Oord EJ.

Metabolomics. 2013 Apr 1;9(2):392-402. Epub 2012 Aug 26.

24.

Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.

Uguen M, Perrin D, Belliard S, Ligneau X, Beardsley PM, Lecomte JM, Schwartz JC.

Br J Pharmacol. 2013 Jun;169(3):632-44. doi: 10.1111/bph.12149.

25.

Glial cell modulators attenuate methamphetamine self-administration in the rat.

Snider SE, Hendrick ES, Beardsley PM.

Eur J Pharmacol. 2013 Feb 15;701(1-3):124-30. doi: 10.1016/j.ejphar.2013.01.016. Epub 2013 Jan 31.

26.

Efficacy of buspirone for attenuating cocaine and methamphetamine reinstatement in rats.

Shelton KL, Hendrick ES, Beardsley PM.

Drug Alcohol Depend. 2013 May 1;129(3):210-6. doi: 10.1016/j.drugalcdep.2013.01.003. Epub 2013 Jan 29.

27.

Prime-, stress-, and cue-induced reinstatement of extinguished drug-reinforced responding in rats: cocaine as the prototypical drug of abuse.

Beardsley PM, Shelton KL.

Curr Protoc Neurosci. 2012;Chapter 9:Unit 9.39. doi: 10.1002/0471142301.ns0939s61.

28.

Evolution education across the life sciences: making biology education make sense.

Wei CA, Beardsley PM, Labov JB.

CBE Life Sci Educ. 2012 Spring;11(1):10-6. doi: 10.1187/cbe.11-12-0111. No abstract available.

29.

The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice.

Snider SE, Vunck SA, van den Oord EJ, Adkins DE, McClay JL, Beardsley PM.

Eur J Pharmacol. 2012 Mar 15;679(1-3):75-80. doi: 10.1016/j.ejphar.2012.01.013. Epub 2012 Jan 28.

30.

Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

McClay JL, Adkins DE, Aberg K, Bukszár J, Khachane AN, Keefe RS, Perkins DO, McEvoy JP, Stroup TS, Vann RE, Beardsley PM, Lieberman JA, Sullivan PF, van den Oord EJ.

Neuropsychopharmacology. 2011 Feb;36(3):616-26. doi: 10.1038/npp.2010.193. Epub 2010 Nov 24.

31.

The selective dopamine uptake inhibitor, D-84, suppresses cocaine self-administration, but does not occasion cocaine-like levels of generalization.

Batman AM, Dutta AK, Reith ME, Beardsley PM.

Eur J Pharmacol. 2010 Dec 1;648(1-3):127-32. doi: 10.1016/j.ejphar.2010.08.051. Epub 2010 Sep 16.

32.

The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse.

Beardsley PM, Shelton KL, Hendrick E, Johnson KW.

Eur J Pharmacol. 2010 Jul 10;637(1-3):102-8. doi: 10.1016/j.ejphar.2010.04.010. Epub 2010 Apr 23.

34.

Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine.

Brunzell DH, Boschen KE, Hendrick ES, Beardsley PM, McIntosh JM.

Neuropsychopharmacology. 2010 Feb;35(3):665-73. doi: 10.1038/npp.2009.171. Epub 2009 Nov 4.

35.
36.

Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders.

Beardsley PM, Thomas BF, McMahon LR.

Int Rev Psychiatry. 2009 Apr;21(2):134-42. doi: 10.1080/09540260902782786. Review.

PMID:
19367507
37.

Effect of drug-paired exteroceptive stimulus presentations on methamphetamine reinstatement in rats.

Shelton KL, Beardsley PM.

Pharmacol Biochem Behav. 2008 Sep;90(3):434-40. doi: 10.1016/j.pbb.2008.03.028. Epub 2008 Apr 4.

38.

Evolution of biogeographic disjunction between eastern Asia and eastern North America in Phryma (Phrymaceae).

Nie ZL, Sun H, Beardsley PM, Olmstead RG, Wen J.

Am J Bot. 2006 Sep;93(9):1343-56. doi: 10.3732/ajb.93.9.1343.

39.

A method for analyzing strain differences in acquisition of IV cocaine self-administration in mice.

Vargas-Irwin C, van den Oord EJ, Beardsley PM, Robles JR.

Behav Genet. 2006 Jul;36(4):525-35. Epub 2006 Apr 4.

PMID:
16586151
40.

Effects of combining ethanol (EtOH) with gamma-hydroxybutyrate (GHB) on the discriminative stimulus, locomotor, and motor-impairing functions of GHB in mice.

Cook CD, Biddlestone L, Coop A, Beardsley PM.

Psychopharmacology (Berl). 2006 Mar;185(1):112-22. Epub 2006 Feb 2.

PMID:
16453156
41.

Effects of memantine, haloperidol, and cocaine on primary and conditioned reinforcement associated with cocaine in rhesus monkeys.

Newman JL, Beardsley PM.

Psychopharmacology (Berl). 2006 Apr;185(2):142-9. Epub 2006 Jan 20.

PMID:
16425059
42.
43.
44.

Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats.

Vann RE, Balster RL, Beardsley PM.

Psychopharmacology (Berl). 2006 Mar;184(3-4):482-93. Epub 2005 Jul 7. Erratum in: Psychopharmacology (Berl). 2006 Mar;184(3-4):652.

PMID:
16001123
45.

Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists.

Batman AM, Munzar P, Beardsley PM.

Psychopharmacology (Berl). 2005 May;179(2):393-401. Epub 2004 Nov 25.

PMID:
15565434
47.

Interaction of noncontingent cocaine and contingent drug-paired stimuli on cocaine reinstatement.

Shelton KL, Hendrick E, Beardsley PM.

Eur J Pharmacol. 2004 Aug 16;497(1):35-40.

PMID:
15302593
48.

Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys.

Beardsley PM, Aceto MD, Cook CD, Bowman ER, Newman JL, Harris LS.

Exp Clin Psychopharmacol. 2004 Aug;12(3):163-72.

PMID:
15301633
49.
50.

Supplemental Content

Loading ...
Support Center